Stocks: DENTSPLY SIRONA Inc (XRAY) Stake Lowered by Flinton Capital Management LLC

Stocks: DENTSPLY SIRONA Inc (XRAY) Stake Lowered by Flinton Capital Management LLC

Flinton Capital Management LLC cut its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 38.8% during the first quarter, Holdings Channel reports. The firm owned 7,104 shares of the medical instruments supplier’s stock after selling 4,512 shares during the period. Flinton Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $444,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XRAY. Advisors Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 10.9% in the first quarter. Advisors Asset Management Inc. now owns 109,273 shares of the medical instruments supplier’s stock valued at $6,823,000 after buying an additional 10,719 shares during the period. First Trust Advisors LP increased its position in shares of DENTSPLY SIRONA by 27.7% in the first quarter. First Trust Advisors LP now owns 297,696 shares of the medical instruments supplier’s stock valued at $18,588,000 after buying an additional 64,530 shares during the period. Northwest Wealth Management LLC increased its position in shares of DENTSPLY SIRONA by 1.4% in the first quarter. Northwest Wealth Management LLC now owns 5,834 shares of the medical instruments supplier’s stock valued at $364,000 after buying an additional 80 shares during the period. Parnassus Investments CA increased its position in shares of DENTSPLY SIRONA by 24.0% in the first quarter. Parnassus Investments CA now owns 1,110,000 shares of the medical instruments supplier’s stock valued at $69,308,000 after buying an additional 215,000 shares during the period. Finally, PBWM Holdings LLC increased its position in shares of DENTSPLY SIRONA by 1.2% in the first quarter. PBWM Holdings LLC now owns 37,231 shares of the medical instruments supplier’s stock valued at $2,325,000 after buying an additional 458 shares during the period. Institutional investors and hedge funds own 94.32% of the company’s stock.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) traded down 1.50% on Friday, reaching $61.76. 538,849 shares of the company’s stock were exchanged. The stock has a market capitalization of $14.21 billion, a PE ratio of 39.74 and a beta of 1.21. The firm has a 50 day moving average of $62.93 and a 200 day moving average of $60.39. DENTSPLY SIRONA Inc has a 12 month low of $55.00 and a 12 month high of $65.83.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by $0.01. The company had revenue of $900.50 million during the quarter, compared to analyst estimates of $916.55 million. DENTSPLY SIRONA had a return on equity of 8.04% and a net margin of 11.15%. The company’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.69 EPS. Equities analysts predict that DENTSPLY SIRONA Inc will post $2.84 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 13th. Stockholders of record on Friday, March 31st were paid a $0.0875 dividend. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Wednesday, March 29th. This represents a $0.35 annualized dividend and a dividend yield of 0.56%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 15.98%.

Several research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $71.00 target price for the company in a research note on Tuesday, May 2nd. Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Tuesday, February 21st. Stifel Nicolaus upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and upped their target price for the company from $62.00 to $70.00 in a research note on Monday, February 13th. Finally, Jefferies Group LLC decreased their target price on shares of DENTSPLY SIRONA from $70.00 to $68.00 and set a “buy” rating for the company in a research note on Monday, January 23rd. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. DENTSPLY SIRONA has an average rating of “Buy” and an average target price of $68.11.

In other news, Director Arthur D. Kowaloff sold 27,213 shares of the firm’s stock in a transaction on Friday, February 17th. The shares were sold at an average price of $62.00, for a total value of $1,687,206.00. Following the sale, the director now owns 55,692 shares in the company, valued at $3,452,904. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Eric Brandt sold 2,941 shares of the firm’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $64.35, for a total transaction of $189,253.35. Following the completion of the sale, the director now owns 4,722 shares in the company, valued at approximately $303,860.70. The disclosure for this sale can be found here. In the last 90 days, insiders sold 405,854 shares of company stock worth $25,560,435. 2.20% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Related posts

Leave a Comment